Marianna Nuti

Pubblicazioni

Titolo Pubblicato in Anno
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice FRONTIERS IN ONCOLOGY 2021
Immunogenic cell death and immunomodulatory effects of cabozantinib FRONTIERS IN ONCOLOGY 2021
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment JOURNAL OF TRANSLATIONAL MEDICINE 2020
Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring JOURNAL OF IMMUNOLOGY RESEARCH 2020
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL VACCINES 2020
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy VACCINES 2020
Incorporating parp-inhibitors in primary and recurrent ovarian cancer. A meta-analysis of 12 phase II/III randomized controlled trials CANCER TREATMENT REVIEWS 2020
The 5-Ws of immunotherapy in head and neck cancer CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1 FRONTIERS IN IMMUNOLOGY 2020
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma JOURNAL OF PERSONALIZED MEDICINE 2020
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma CANCERS 2020
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL) CANCERS 2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients JOURNAL OF PERSONALIZED MEDICINE 2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells EBIOMEDICINE 2020
Network analysis of gut microbiome and metabolome to discover microbiota-linked biomarkers in patients affected by non-small cell lung cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells ANNALS OF ONCOLOGY 2020
Bevacizumab-based chemotherapy triggers Immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector T Cell Subsets JOURNAL OF CLINICAL MEDICINE 2019
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019
Immunological backbone of uveal melanoma: is there a rationale for immunotherapy? CANCERS 2019
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab JOURNAL OF TRANSLATIONAL MEDICINE 2019

ERC

  • LS2_15
  • LS4_6
  • LS4_12
  • LS6
  • LS6_3
  • LS6_10
  • LS7_2

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Precision Medicine with particular interest in tumor immunology and the identification of mechanisms involved in the tumor- immunity interaction. Development of strategies for the activation of immunity in cancer patients and reduction of immunosuppression. Identification of biomarkers in immunity. Identification and study of the Interactions of drugs and targeted therapy with the immune systems of cancer patiemts. Immunotherapy clinical trials.

Keywords

tumor immunology
precision medicine
anticancer immunotherapy
Cancer vaccines

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma